Vivos (RDGL) Gross Profit Growth (3y) (2013 - 2025)
Powered by 
Analysis
Vivos (RDGL) Gross Profit Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 9.77% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 18.71% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 7.71% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 12.24% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 14.82% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 9.36% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 7.11% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 14.95% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 8.95% |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 9.77% |
| Sep 30, 2025 | -25.17% |
| Jun 30, 2025 | -82.69% |
| Mar 31, 2025 | -42.74% |
| Dec 31, 2024 | 4.14% |
| Sep 30, 2024 | -50.45% |
| Dec 31, 2015 | -31.60% |
| Sep 30, 2015 | -34.53% |
| Jun 30, 2015 | -26.03% |
| Mar 31, 2015 | -38.08% |
| Dec 31, 2014 | -33.44% |
| Sep 30, 2014 | -26.14% |
| Jun 30, 2014 | -57.66% |
| Mar 31, 2014 | -52.09% |
| Dec 31, 2013 | -26.05% |
| Sep 30, 2013 | -42.50% |